Trivium Point Advisory’s Merck MRK Stock Holding History

Trivium Point Advisory’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.58M	Sell	13,101 -2,562	-16%	-$296K	0.28%	87
2025 Q4	$1.65M	Buy	15,663 +536	+4%	+$50.3K	0.17%	132
2025 Q3	$1.27M	Sell	15,127 -1,181	-7%	-$97.3K	0.13%	151
2025 Q2	$1.29M	Buy	16,308 +2,212	+16%	+$176K	0.14%	152
2025 Q1	$1.27M	Sell	14,096 -1,209	-8%	-$113K	0.16%	148
2024 Q4	$1.52M	Buy	15,305 +1,057	+7%	+$109K	0.19%	132
2024 Q3	$1.4M	Sell	14,248 -1,592	-10%	-$189K	0.2%	132
2024 Q2	$1.96M	Buy	15,840 +267	+2%	+$34.4K	0.29%	100
2024 Q1	$2.05M	Sell	15,573 -1,034	-6%	-$127K	0.44%	67
2023 Q4	$1.81M	Sell	16,607 -1,169	-7%	-$121K	0.44%	70
2023 Q3	$1.81M	Sell	17,776 -218	-1%	-$23.5K	0.5%	67
2023 Q2	$2.08M	Sell	17,994 -4,163	-19%	-$473K	0.56%	63
2023 Q1	$2.36M	Buy	22,157 +401	+2%	+$43.3K	0.64%	49
2022 Q4	$2.5M	Buy	21,756 +5	+0%	+$511	0.73%	41
2022 Q3	$1.9M	Sell	21,751 -2,563	-11%	-$229K	0.59%	53
2022 Q2	$2.26M	Sell	24,314 -490	-2%	-$43.4K	0.68%	44
2022 Q1	$2.11M	Buy	24,804 +2,492	+11%	+$196K	0.47%	74
2021 Q4	$1.71M	Sell	22,312 -14	-0.1%	-$1.11K	0.36%	91
2021 Q3	$1.83M	Sell	22,326 -510	-2%	-$38.8K	0.43%	77
2021 Q2	$1.78M	Sell	22,836 -2,287	-9%	-$170K	0.44%	85
2021 Q1	$1.85M	Sell	25,123 -1,059	-4%	-$78.1K	0.5%	73
2020 Q4	$2.1M	Sell	26,182 -230	-0.9%	-$17.6K	0.61%	49
2020 Q3	$2.09M	Sell	26,412 -140	-0.5%	-$11K	0.74%	41
2020 Q2	$2.02M	Buy	26,552 +317	+1%	+$23.9K	0.8%	37
2020 Q1	$2.04M	Sell	26,235 -866	-3%	-$68.1K	1.05%	29
2019 Q4	$2.35M	Buy	27,101 +555	+2%	+$45.6K	0.91%	27
2019 Q3	$2.13M	Buy	26,546 +152	+0.6%	+$12.2K	0.98%	28
2019 Q2	$2.11M	Sell	26,394 -466	-2%	-$35.7K	0.94%	27
2019 Q1	$2.13M	Sell	26,860 -732	-3%	-$54.7K	1%	23
2018 Q4	$2.01M	Buy	+27,592	New	+$1.95M	1.22%	16

Other funds holding MRK

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Trivium Point Advisory's MRK Position: Q1 2026 in Review

Trivium Point Advisory reduced its Merck (MRK) stake by 16% in Q1 2026, selling an estimated $296K and leaving 13,101 shares worth $1.58M. The position accounts for 0.28% of the portfolio, ranked #87.

Trivium Point Advisory first reported a position in MRK in Q4 2018 and has held it in 30 quarters since. The position peaked at $2.5M in Q4 2022. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

Trivium Point Advisory held 13,101 shares of Merck worth $1.58M as of Q1 2026.
Trivium Point Advisory sold 2,562 Merck shares in Q1 2026, an estimated $296K.
Merck made up 0.28% of Trivium Point Advisory's portfolio in Q1 2026, its #87 holding.
Trivium Point Advisory first reported a position in Merck in Q4 2018 and has held it in 30 quarters since.
Trivium Point Advisory's Merck position peaked at $2.5M in Q4 2022.
3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Trivium Point Advisory's 13F filing for Q1 2026, filed 21 Apr 2026.